TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Massachusetts Investigators

Nikhil Munshi, MD

Dana-Farber Cancer Institute


Boston, Massachusetts - 02115

Dana Farber


Boston, Massachusetts - 02115

Dana Faber Cancer Institute


Boston, Massachusetts - 02115

Massachusetts General Hospital


Boston, Massachusetts - 02114

Dana-Farber Cancer Institute/Brigham & Women's ...


Boston, Massachusetts - 02115
  • CLINICAL TRIALS 7
  • CONDITIONS4
  • INTERVENTIONS12
  • SINCE2005
Blockage of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation

March 2010 - March 2013
Study on the Anti-tumor Activity Safety and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First Relapse

September 2010 - March 2014
A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients

January 2009 - November 2010
Bortezomib Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma

August 2006 - August 2010
Study on the Anti-tumor Activity Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma

September 2010 - September 2013
Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates

October 2007 - October 2010
Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma

April 2005 - September 2011
Multiple Myeloma

Neoplasms, Plasma Cell

Bone Diseases

Recurrence

Placebo

Zoledronic Acid

Lenalidomide

Ct-011

Dendritic Cell Fusion Vaccine

Bortezomib

Dexamethasone

Iph2101 Combined To Lenalidomide

Bhq880

Iph2101 0.2 Mg/Kg

Iph2101 2 Mg/Kg

Dendritic Cell Tumor Fusion

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo